Chart still looks bullish on the daily and only suffering from general market sentiment IMO.
Not many biotech plays that generate positive cashflows. Minimal prospects of dilution, extremely tight register, many irons in the fire, unlimited blue sky potential given time. This is no brainer for me.
Ann: December 2020 Quarterly Activities Report and Appendix 4C, page-14
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
85.0¢ |
Change
-0.020(2.30%) |
Mkt cap ! $111.3M | |||
| Open | High | Low | Value | Volume |
| 87.0¢ | 88.0¢ | 84.5¢ | $104.5K | 121.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 12500 | 85.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 87.0¢ | 2526 | 1 |
View Market Depth
| Last trade - 15.32pm 15/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |